Ilaria Cetta

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference.

An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference.

Journal: Expert review of neurotherapeutics

Published: June 20, 2026

Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report.

Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report.

Journal: Journal of neurology

Published: September 29, 2025

Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.

Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis.

Journal: Cephalalgia : an international journal of headache

Published: October 09, 2024

Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Journal: Journal of neurology

Published: April 02, 2024

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Journal: European journal of neurology

Published: March 06, 2024

The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study.

The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study.

Journal: The journal of headache and pain

Published: December 29, 2023

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Journal: Journal of neurology

Published: October 03, 2023

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).

Journal: Journal of neurology

Published: June 08, 2023

Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.

Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study.

Journal: Journal of neurology

Published: May 07, 2023

Imaging the brain and vascular reactions to headache treatments: a systematic review.

Imaging the brain and vascular reactions to headache treatments: a systematic review.

Journal: The journal of headache and pain

Published: March 14, 2023

Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience.

Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience.

Journal: European journal of neurology

Published: February 23, 2023

Tracking the evolution of non-headache symptoms through the migraine attack.

Tracking the evolution of non-headache symptoms through the migraine attack.

Journal: The journal of headache and pain

Published: August 18, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026